FDA

Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements
Office of Minority Health Targeted as RFK Jr. Drives Deep Cuts Across CMS
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements
Office of Minority Health Targeted as RFK Jr. Drives Deep Cuts Across CMS
RFK Jr. Spreading 'Misinformation and Lies'? FDA's Top Vaccine Official Walks Out, Sparking Debate on Safety and Public Trust
Acne Products At Walgreens Flagged For Benzene, Recalls Announced

FDA Recent News

FDA Approves First Non-Opioid Pain Pill, As Medical Marijuana Remains A Proven Alternative For Relief
FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide patients with more options.
|
Ozempic Receives FDA Approval To Treat Kidney Disease
The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease in patients who also have type 2 diabetes. 
|
Sanofi Genzyme Facility Draws FDA Criticism Over Alleged Quality Lapses
FDA issues warning letter to Sanofi over its Genzyme facility, citing process deviations, equipment issues, and quality oversight lapses.
|
Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug
The FDA approved Eli Lilly's Zepbound as the first drug for obesity-linked moderate-to-severe sleep apnea, potentially transforming treatment options for 80 million Americans.
|
Supreme Court Hears Case Against FDA Ban On Flavored Vapes: Here Are The Stocks To Watch
A Supreme Court ruling on a case against the FDA could change the e-cigarette and vaping market.
|
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.
|
FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays
FDA approves Phase 2 cannabis trial for veterans with PTSD, funded by Michigan marijuana taxes. Study to assess smoked cannabis efficacy.
|
FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment
FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory hurdles.
|
Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'
Donald Trump has said he will give Robert F. Kennedy Jr. a senior role in his incoming administration to advance his "Make America Healthy Again" agenda.
|
Trump Says Robert Kennedy Jr. Can Run Wild On Health And Food: 'I'm Going To Let Him Go Wild On The Medicines'
Donald Trump plans to give Robert F. Kennedy Jr. major control over health, food, and medicine matters if re-elected, except for oil.
|
McDonald's Rivals Burger King, Yum Brands Remove Onions From Menus Amid Quarter-Pounder E.Coli Scare
|
FDA Launches Investigation Into McDonald's Supplier Taylor Farms Following E. Coli Outbreak
The Food and Drug Administration (FDA) has launched an investigation into Taylor Farms, a supplier for McDonald's Corporation (NYSE:MCD), after multiple people fell ill with E. coli linked to the restaurant chain's Quarter Pounder.
|
FDA Rejection Of MDMA Could Fuel Black Market Demand, Warns CEO Of Women's Psychedelic Platform SetSet
The FDA rejected MDMA-assisted therapy for PTSD. SetSet's April Pride calls for harm-reduction education and regulatory change.
|
FDA Sets September Meeting To Discuss Psychedelic And Other Treatments For PTSD
FDA schedules public meeting to discuss potential psychedelic treatments for PTSD, inviting input from veterans, advocates and researchers
|
Regeneron Faces Setback With FDA Rejection Of Blood-Cancer Treatment
Regeneron Pharmaceuticals Inc. has received a setback as the Food and Drug Administration has declined its application for a blood cancer treatment.
|
FDA Backs Off Joint Study On Kratom And Psychedelics Amidst Public Criticism
The FDA withdraws its request to study kratom and psychedelics risks, following public criticism and accusations of bias against harm reduction strategies.
|
FDA Rejects MDMA For PTSD Treatment, Calls For More Research On Psychedelic Therapy
The FDA this week declined to approve the use of MDMA — popularly known as Ecstasy or Molly — for MDMA-assisted therapy for treating PTSD.
|
FDA Poised To Make Historic Decision On MDMA Therapy To Treat PTSD: Here's How Things Stand
The FDA is set to decide on MDMA therapy for PTSD, a move that could revolutionize treatment for veterans and others with severe trauma. Here's what's at stake
|

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved